Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Euronext Amsterdam  >  Royal DSM N.V.    DSM   NL0000009827

ROYAL DSM N.V.

(DSM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

DSM reports in-line quarterly results, suspends outlook

share with twitter share with LinkedIn share with facebook
05/07/2020 | 01:39am EDT
DSM logo is seen at the headquarters in Heerlen

Dutch speciality chemicals maker DSM NV on Thursday reported first-quarter core earnings in line with estimates, but suspended its annual outlook amid market uncertainty caused by the coronavirus crisis.

Adjusted earnings before interest, taxes, depreciation and amortization (EBITDA) came in at 423 million euros ($457 million), in-line with a company compiled poll, and down fractionally from 424 million euros posted last year.

Sales were flat at 2.29 billion euros.

The Dutch company expects an about 5% increase in adjusted EBITDA for its nutrition division, but said it is too early to provide an overall outlook as it has limited visibility on earnings from its materials division.

(Reporting by Toby Sterling, Editing by Sherry Jacob-Phillips)

Stocks mentioned in the article
ChangeLast1st jan.
AMP LIMITED -0.55% 1.815 End-of-day quote.-5.22%
DOWNING STRATEGIC MICRO-CAP INVESTMENT TRUST PLC -3.00% 48.5 Delayed Quote.-33.33%
EURO / BRITISH POUND (EUR/GBP) 0.42% 0.90549 Delayed Quote.6.57%
ROYAL DSM N.V. 1.12% 126.3 Delayed Quote.7.58%
THE NEW HOME COMPANY INC. 0.63% 3.22 Delayed Quote.-31.33%
share with twitter share with LinkedIn share with facebook
Latest news on ROYAL DSM N.V.
07/01ROYAL DSM N : Appoints Zhou Tao (Joe) as DSM China President
PU
06/30ROYAL DSM N : DSM halves the carbon footprint of Akulon® PA6
PU
06/24ROYAL DSM N : DSM takes over part of Clariant's 3D printing business portfolio t..
PU
06/17ROYAL DSM N : DSM issues €1 billion long-term bonds to finance acquisition of Er..
PU
06/12ROYAL DSM N : DSM finalizes share repurchase to cover share plans and stock divi..
PU
06/12ROYAL DSM N : DSM to add world-leading animal nutrition and health specialty bus..
PU
06/02ROYAL DSM N : DSM introduces Again™, commercial carpet designed for circul..
PU
05/19ROYAL DSM N : Open collaborative platform UNITE4COVID launched to accelerate Cov..
PU
05/13ROYAL DSM : Presentation to AGM
PU
05/12ROYAL DSM : Ex-dividend day for final dividend (optional)
FA
More news
Financials
Sales 2020 8 893 M 10 057 M 10 057 M
Net income 2020 757 M 856 M 856 M
Net Debt 2020 2 151 M 2 433 M 2 433 M
P/E ratio 2020 28,5x
Yield 2020 1,99%
Capitalization 21 205 M 23 979 M 23 981 M
EV / Sales 2019
EV / Sales 2020 2,63x
Nbr of Employees 22 174
Free-Float 94,7%
Chart ROYAL DSM N.V.
Duration : Period :
Royal DSM N.V. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends ROYAL DSM N.V.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 117,14 €
Last Close Price 124,90 €
Spread / Highest target 17,1%
Spread / Average Target -6,22%
Spread / Lowest Target -41,6%
EPS Revisions
Managers
NameTitle
Dimitri de Vreeze Co-Chief Executive Officer & COO
Géraldine Matchett Co-Chief Executive Officer & CFO
Robert John Routs Chairman-Supervisory Board
Pauline F. M. van der Meer Mohr Deputy Chairman
Eileen A. Kennedy Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
ROYAL DSM N.V.7.58%23 839
BASF SE-25.06%52 114
SHIN-ETSU CHEMICAL CO., LTD.3.86%48 253
DUPONT DE NEMOURS, INC.-16.32%39 420
GROUPE BRUXELLES LAMBERT-19.37%13 250
FMC CORPORATION1.32%13 092